World of DTC Marketing

JULY 21, 2021

SUMMARY: DTC marketing is not the reason why prescription drugs cost so much. The voices in Washington DC are once again calling for a moratorium on DTC marketing but lawmakers need to understand what DTC marketing actually does as upped to what people believe it does. DTC ads raise awareness around health conditions.

Marketing 285

Marketing Doctors Doctor Drugs 285

World of DTC Marketing

AUGUST 4, 2021

Pharma websites are not consdiered a top resource for infromation on new products. TV spots are the number one way people learn about new pharma products. 3hree: Pharma product websites are not listed as a top online health resource even when looking for information on a specific product. WebMD is still number one.

Marketing 279

Marketing Pharma Production Production Drugs 279

Pharmaceutical Technology

JUNE 12, 2023

Lotus Pharmaceuticals and Teraju Pharma have entered a strategic partnership to market Lotus’s products in a range of therapeutic areas in Malaysia. Teraju Pharma will be responsible for marketing and promoting the products using its relationships and infrastructure.

Marketing 242

Marketing Production Branding Manufacturing 242

XTalks

OCTOBER 23, 2024

Oxford Medical Products has shared promising safety data from a first-in-human study for its ‘mechanical’ weight loss pill. Oxford’s device showed a favorable safety profile, with no serious adverse events reported, and no participants withdrew from the study due to product-related issues.

Production 104

Production Hormones Drugs Trials 104

Pharmaceutical Technology

JUNE 19, 2023

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

Gene Therapy 246

Gene Therapy Gene Production Pharma Companies 246

World of DTC Marketing

JANUARY 4, 2021

KEY TAKEAWAY: Consumer behavior has changed due to the pandemic, and DTC marketers should be aware of how consumers will evaluate and choose prescription drugs. Many organizations have postponed market research due to the pandemic but knowledgeable DTC marketers should be aware of the progressive trends in healthcare.

Marketing 271

Marketing Branding Engineer Doctors 271

Pharmaceutical Technology

FEBRUARY 28, 2023

Breakthroughs in therapies containing monoclonal antibodies (mAbs) are showing ever-greater potential in treating a range of diseases, alongside biopharma manufacturers facing the challenge of keeping up with demand for production while controlling costs. More than 100 treatments are currently on the market, with hundreds more on their way.

Production 237

Production Manufacturing Engineer Containment 237

Pharmaceutical Technology

APRIL 27, 2023

The European Commission’s (EC) long-anticipated pharma reform plans in the European Union have finally been unveiled , indicating a focus on improving access to medicines across the bloc while cutting down on market exclusivity. Along with the patent-related changes, the EC is seeking to ease some of the regulatory steps.

Marketing 264

Marketing Medicine Production Clinical Trials 264

Bio Pharma Dive

MAY 22, 2023

When pharma manufacturers are racing to bring a new product to market, catastrophic printing errors and mislabeled materials can have a significant impact on timelines and budgets.

Marketing 246

Marketing Manufacturing Production 246

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. Croda Pharma and BSI will share their knowledge to bring QS-21 to market from quillaja Saponaria plant cell culture, which is made from the soap bark tree.

Vaccine 240

Vaccine Vaccination Production Life Science 240

Pharmaceutical Technology

OCTOBER 18, 2024

Late-stage pipeline products could drive combined sales of approximately $171.4 million by 2033 in the 8MM.

Sales 269

Sales Marketing Production 269

World of DTC Marketing

APRIL 21, 2022

I can get better results using digital laser targeting and targeted print ads, but DTC marketers are like TV because it makes them feel important within their company. ” Marketers were tapped to develop a model that showed the patient’s journey to getting an Rx. The post DTC marketers addicted to TV.

Marketing 227

Marketing Branding Drugs Development 227

Pharmaceutical Technology

APRIL 3, 2023

The European Commission (EC) has granted marketing authorisation for Sandoz’s biosimilar Hyrimoz (adalimumab) citrate-free high-concentration formulation (HCF). The regulatory approval comes after a positive opinion was issued by the European Medicines Agency’s Committee on Medicinal Products for Human Use (CHMP) in January this year.

Marketing 264

Marketing Medicine Packaging Packaging 264

Drug Patent Watch

JANUARY 13, 2025

As we delve into the intricate world of biosimilar market dynamics, we’ll explore how these complex molecules are reshaping treatment paradigms across diverse patient populations. ”[1] The global biosimilars market is experiencing exponential growth, with projections indicating it will reach $69.4 from 2020 to 2025[1].

Marketing 78

Marketing Insulin Generic Drugs Medicine 78

Pharmaceutical Technology

MAY 26, 2023

The immuno-oncology market continues to evolve as treatments establish their presence across different types of cancer, having seen approvals in multiple indications in the past decade. There are currently over 700 immuno-oncology products in Phase I-III of development in the eight major markets, said Chalk.

Marketing 264

Marketing Vaccine Vaccination Development 264

Pharmaceutical Technology

APRIL 13, 2023

With challenges around the R&D, clinical trials, pricing, and market access for these rare disease therapeutics, big pharma often collaborates with specialist biotechnology companies as a method of de-risking the development of gene therapy products.

Gene Therapy 243

Gene Therapy Marketing Gene In-Vivo 243

Bio Pharma Dive

NOVEMBER 4, 2024

As novel therapeutics become more complex — and costly — to bring to market, drug developers are looking to unified clinical development platforms to streamline operations.

Production 204

Production Clinical Development Development Marketing 204

Pharmaceutical Technology

MAY 2, 2024

Novo Nordisk noted a 22% boost in sales owing to increased sales of GLP-1 agonists and other obesity products.

Sales 246

Sales Marketing Production 246

Bio Pharma Dive

MAY 18, 2021

CEO Richard Gonzalez defended the company's practices, arguing its profits help spur innovation: "The products that are on the market today pay for the products of the future," he said.

Production 327

Production Marketing 327

Drug Patent Watch

JANUARY 29, 2025

As we navigate the complex world of healthcare, it's easy to overlook the intricacies of generic drug production. Generic drug production involves replicating a brand-name medication's active ingredient, formulation, and dosage. The quality and purity of these ingredients can greatly impact the final product's efficacy and safety.

Generic Drugs 78

Generic Drugs Production Compliance Drugs 78

XTalks

FEBRUARY 5, 2025

The approval marks Celltrions seventh biosimilar to be granted marketing authorization in the US and its fifth immunology biologic approval. The FDAs decision was based on comprehensive data demonstrating biosimilarity between Avtozma and the reference product, Actemra. It also has EUA for children aged between two and 18.

FDA Approval 102

FDA Approval Marketing Antibody Immune Response 102

Bio Pharma Dive

MAY 21, 2021

The treatment, for a progressive, often deadly brain disease, could soon become Bluebird's third approved product and one of only a handful of marketed gene therapies in the world.

Gene Therapy 330

Gene Therapy Gene Regulation Production 330

Pharmaceutical Technology

APRIL 4, 2025

Late-stage pipeline products anticipated to reach the uveitis market during the forecast period will introduce new mechanisms of action.

Marketing 130

Marketing Production 130

Bio Pharma Dive

JULY 29, 2021

An injectable insulin from Viatris has become the first-ever biosimilar product that can be directly substituted for a marketed biologic, a long-awaited decision that could put pricing pressure on other diabetes drugs.

FDA Approval 324

FDA Approval Insulin Production Marketing 324

Drug Patent Watch

JANUARY 30, 2025

Maximizing Patent Protection: Strategies for Pharmaceutical Marketers As a pharmaceutical marketer, you know how crucial it is to protect your patented drug's market share. In this post, we'll explore effective strategies for maximizing patent protection and exclusivity, ensuring your product remains a leader in the market.

Marketing 59

Marketing Drugs Production Sales 59

Worldwide Clinical Trials

NOVEMBER 12, 2024

Despite their exciting potential, the smooth operation of cell therapy development trials requires extraordinary orchestration, perfectly aligning the product and patient journeys. Delivering this cellular drug product into the patient’s body, followed by intensive medical oversight.

Gene Therapy 182

Gene Therapy Clinical Supply Trials Gene 182

Bio Pharma Dive

SEPTEMBER 19, 2022

Elevate pharma product development and marketing through collaboration with physician experts

Pharma Production 281

Pharma Production Production Marketing Development 281

Bio Pharma Dive

NOVEMBER 3, 2022

The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product.

Sales 297

Sales Vaccination Vaccine Production 297

Bio Pharma Dive

SEPTEMBER 13, 2024

During an investor presentation Thursday, executives admitted to being overly optimistic their vaccine could wrest significant market share away from GSK's and Pfizer's products this year.

Vaccine 270

Vaccine Vaccination Production Marketing 270

Drug Patent Watch

MARCH 13, 2025

From manufacturing and quality control to distribution and regulatory compliance, the stakes are high for pharmaceutical companies looking to bring these life-changing treatments to market. So, what can biosimilar manufacturers do to address these supply chain challenges and bring their products to market efficiently and effectively?

Production 52

Production Compliance Manufacturing Marketing 52

XTalks

DECEMBER 19, 2024

Roches Alecensa is the current ALK inhibitor market leader. billion Chinese yuan ($321 million), derived from five products, including ensartinib in China. The intracranial response rate, as confirmed by a blinded independent review committee, was 63.6 percent (seven out of 11) for patients treated with ensartinib compared to 21.1

FDA Approval 98

FDA Approval Marketing Trials Drugs 98

Bio Pharma Dive

MARCH 11, 2024

Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS.

Production 297

Production Marketing Drugs 297

World of DTC Marketing

DECEMBER 28, 2020

As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. DTC marketers need to fall out of love with TV and think about how they translate awareness into brand objectives. Let’s be clear about pharma product websites.

Doctors 296

Doctors Doctor Production Marketing 296

Pharmaceutical Technology

FEBRUARY 8, 2023

The top 20 companies in the global biopharma industry saw 5.4%* aggregate market capitalization from $3.43 Pfizer maintained its third-place position in the market in 2022, reporting a market capitalization of $287.6 witnessed the biggest market capitalization growth of 45.3% trillion to $3.61 billion on Dec 31, 2022.

Marketing 195

Marketing Sales Vaccine Vaccination 195

Pharma Marketing Network

MARCH 26, 2025

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster? Key pillars include: 1.

Compliance 52

Compliance Marketing Regulation Pharma Companies 52

World of DTC Marketing

JULY 8, 2021

Some of the TV spots for drugs are horrible, and some products should even be on TV because of terrible fair balance. One of the reasons for such bad TV is the lack of talent within DTC marketing. It’s estimated that DTC marketers spend 76% of their budgets on TV ads. Agencies are equally responsible for bad DTC TV.

Contamination 297

Contamination Production Marketing Drugs 297

Fierce Pharma

DECEMBER 3, 2024

Over the last two-plus years, as Eli Lilly and Novo Nordisk have battled for their share of the massive weight loss market and patients wondered which company’s products were more effective, there | Eli Lilly revealed results from a study that showed its obesity drug Zepbound was 47% more effective than Novo’s Wegovy in helping patients lose weight. (..)

Trials 114

Trials Production Marketing Drugs 114